Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alpine Immune Sciences Inc. (ALPN)

3.12   -0.21 (-6.31%) 02-20 15:59
Open: 3.33 Pre. Close: 3.33
High: 3.33 Low: 3.05
Volume: 46,731 Market Cap: 61M
Nivalis Therapeutics Inc a pharmaceutical company, focuses on the discovery and development of product candidates for patients with cystic fibrosis. Geographically operation of the group is functioned through United States.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.332 - 3.349 3.349 - 3.362
Low: 3.013 - 3.03 3.03 - 3.042
Close: 3.093 - 3.122 3.122 - 3.143

Technical analysis

as of: 2020-02-20 4:37:38 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.29     One year: 4.98
Support: Support1: 2.73    Support2: 2.27
Resistance: Resistance1: 3.68    Resistance2: 4.26
Pivot: 3.03
Moving Average: MA(5): 3.11     MA(20): 3.04
MA(100): 3.21     MA(250): 4.49
MACD: MACD(12,26): -0.08     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 75.54     %D(3): 67.29
RSI: RSI(14): 48.14
52-week: High: 8.24  Low: 2.25  Change(%): -53.0
Average Vol(K): 3-Month: 1994  10-Days: 2811

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ALPN has closed below upper band by 29.6%. Bollinger Bands are 59.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALPN's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Alpine Select rechnet 2019 mit Gewinn
Das Unternehmen rechnet für 2019 mit einem Gewinn in Höhe von rund 13 Millionen Franken nachdem 2018 noch ein Verlust von 15,8 Millionen resultiert hatte, teilte Alpine Select am Montagabend ohne weitere Details mit. Alpine Select hatte bereits im ersten…

Alpine Immune Sciences up 8% premarket on encouraging data on lead candidate
Thinly traded nano cap Alpine Immune Sciences (NASDAQ:ALPN) is up 8% premarket, albeit on only 1,008 shares, on the heels of new preclinical data on lead c

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18.59
Shares Float (M) 3.96
% Held by Insiders 40.62
% Held by Institutions 45.20
Shares Short (K) 20
Shares Short P. Month (K)

Stock Financials

EPS -2.728
Book Value (p.s.) 1.870
PEG Ratio
Profit Margin
Operating Margin -5607.71
Return on Assets (ttm) -46.4
Return on Equity (ttm) -104.3
Qtrly Rev. Growth
Gross Profit (p.s.) -1.521
Sales Per Share
EBITDA (p.s.) -2.558
Qtrly Earnings Growth
Operating Cash Flow (M) -39.07
Levered Free Cash Flow (M) -22.30

Stock Valuations

P/E -1.14
P/E Growth Ratio -0.06
P/BV 1.67
P/S 62.40
P/CF -1.48

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-07-24
Last Split Ratio 0.25
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.